Clinical Trials Directory

Trials / Unknown

UnknownNCT02573805

the Diagnostic Value of Rigiscan Test (Nocturnal Penile Tumescence and Rigidity, NPTR) in Chinese Males

the Evaluation of Diagnostic Value of Rigiscan Test (Nocturnal Penile Tumescence and Rigidity, NPTR) in Chinese Males

Status
Unknown
Phase
Study type
Observational
Enrollment
1,000 (estimated)
Sponsor
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School · Academic / Other
Sex
Male
Age
20 Years – 65 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to evaluate the diagnostic value of Rigiscan (nocturnal penile tumescence and rigidity, NPTR ) test in erectile dysfunction of Chinese males.

Detailed description

The Rigiscan test is used to evaluate the NPTR parameters. The "normal" NPTR parameter is provided by the Rigiscan manufacturer based on a clinical study on 500 American males. Original studies of NPTR parameters on Chinese males are warranted. On the other hand, during the past decades, several new NPTR parameters have been developed, like tip TAU (tip tumescence activity units), tip RAU (tip rigidity activity units), base TAU (base tumescence activity units), base RAU (base rigidity activity units), but their diagnostic values have been less evaluated. Basd on the these background, we determined to observe the clinical manifestation of these new parameters and to establish the "normal criteria" of NPTR parameters in Chinese males. This could be clinically beneficial in the differential diagnosis of organic and psychological erectile dysfunction.

Conditions

Interventions

TypeNameDescription
DEVICERigiscan testRigiscan tests are performed in enrolled subjects for consecutive two nights.

Timeline

Start date
2015-09-01
Primary completion
2016-08-01
Completion
2016-10-01
First posted
2015-10-12
Last updated
2015-10-14

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02573805. Inclusion in this directory is not an endorsement.